Ani Pharmaceuticals (ANIP) Preferred Dividend Payments (2012 - 2025)

Ani Pharmaceuticals has disclosed Preferred Dividend Payments across 7 years of filings, most recently posting $344000.0 for Q3 2025.

• In Q3 2025, Preferred Dividend Payments fell 15.27% year-over-year to $344000.0; the TTM figure through Jun 2026 stood at $344000.0 (down 78.83% YoY), while the FY2025 annual figure was $1.2 million, down 28.8% from the prior year.
• Preferred Dividend Payments came in at $344000.0 for Q3 2025 at Ani Pharmaceuticals, down from $407000.0 in the prior quarter.
• In the past five years, Preferred Dividend Payments ranged from a high of $407000.0 in Q2 2022 to a low of $190000.0 in Q4 2021.
• Average Preferred Dividend Payments over 5 years is $388875.0, with a median of $406000.0 recorded in 2022.
• Year-over-year, Preferred Dividend Payments soared 114.21% in 2022 and slipped 15.27% in 2025.
• Over 5 years, Preferred Dividend Payments stood at $190000.0 in 2021, then jumped by 114.21% to $407000.0 in 2022, then decreased by 0.25% to $406000.0 in 2023, then changed by 0.0% to $406000.0 in 2024, then retreated by 15.27% to $344000.0 in 2025.
• Per Business Quant data, the three most recent Preferred Dividend Payments figures were $344000.0 in Q3 2025, $407000.0 in Q2 2025, and $406000.0 in Q1 2025.